The Trial to Assess Chelation Therapy - TACT


Chelation therapy with disodium ethylene diamine tetra acetic acid (EDTA) is sometimes suggested as an alternative medicine approach to the treatment of coronary artery disease (CAD). However, there are limited data to support its use. The current trial sought to compare outcomes with EDTA versus placebo infusion in post-myocardial infarction (MI) patients treated with medical therapy.